NextCure Statistics
NASDAQ: NXTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.78+0.22 (+3.35%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 6.78 0.00%
NextCure by the numbers
NextCure has a market capitalization of $31.0 million based on 4.58M shares outstanding. With trailing EPS of $-8.71, NextCure is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.8% above its 50-day average and 19.7% below its 200-day average.
Average daily trading volume is 2.11M shares, or about $14.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NXTC valuation vs. peer median
| Metric | NXTC | Peer median | Difference |
|---|---|---|---|
| Market cap | $31.03M | $30.93M | +0% |
| Avg. volume | 2.11M | 209.78K | +908% |
Peer median across 8 companies: RMTI, MIRA, IGC, RNAZ, NNVC, IMMP, ATNM, BCTX.
Valuation
- Market cap
- $31.03M
- EPS (TTM)
- $-8.71
- Shares outstanding
- 4.58M
Price and trading
- Previous close
- 6.56
- Open
- 6.24
- Day range
- 6.05 – 6.94
- 52-week range
- 1.55 – 15.74
- 52-week change
- +7.07%
- Beta
- —
- Volume
- 82.60K
- Average volume
- 2.11M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 31.03M
- Forward Pe
- -1.15
- Eps
- -8.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.74
- Week52 Low
- 1.55
- Avg Volume
- 2.11M
- Shares Outstanding
- 4.58M
- Ma50
- 6.17
- Ma200
- 8.45
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -56.93%
- Pct From52w Low
- 337.42%